Sign in

Private company

Synaffix

Logo: Techflash5342, CC BY-SA 4.0, via Wikimedia Commons3

Dutch biotechnology company

Synaffix is a Dutch biotechnology company headquartered in the Netherlands that has developed a clinical-stage platform technology for antibody-drug conjugates (ADCs), primarily used for cancer treatment. ADCs utilize potent small molecule payloads, similar to those used in chemotherapy, but are designed to target only cancer cells, sparing normal, healthy tissues.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2010Founded1

See how the biggest companies compare on our leaderboards

Synaffix aerial shot
Photo: Techflash5342, CC BY-SA 3.0, via Wikimedia Commons4

Synaffix is a Dutch biotechnology company headquartered in the Netherlands that has developed a clinical-stage platform technology for antibody-drug conjugates (ADCs), primarily used for cancer treatment. ADCs utilize potent small molecule payloads, similar to those used in chemotherapy, but are designed to target only cancer cells, sparing normal, healthy tissues.2

Timeline

  1. 2010Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4